Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Aletekitug in Colitis, Ulcerative: NCT07747467 Clinical Landscape Report 2026
16 September 2026
NCT07747467 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PTT-621 in Colitis, Ulcerative: NCT07747155 Clinical Landscape Report 2026
16 September 2026
NCT07747155 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ONO-6414 in Colitis, Ulcerative: NCT07749768 Clinical Landscape Report 2026
16 September 2026
NCT07749768 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lecankitug in Plaque psoriasis: NCT07746479 Clinical Landscape Report 2026
16 September 2026
NCT07746479 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in Unresectable Hepatocellular Carcinoma: NCT07749859 Clinical Landscape Report 2026
16 September 2026
NCT07749859 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
NBL-023 in Dermatitis, Atopic: NCT07746817 Clinical Landscape Report 2026
16 September 2026
NCT07746817 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab govitecan-hziy in ALK positive Non-Small Cell Lung Cancer: NCT07750704 Clinical Landscape Report 2026
16 September 2026
NCT07750704 clinical landscape for ALK positive Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
JNJ-98768111 in Advanced Prostate Carcinoma: NCT07746713 Clinical Landscape Report 2026
16 September 2026
NCT07746713 clinical landscape for Advanced Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Unresectable Hepatocellular Carcinoma: NCT07746960 Clinical Landscape Report 2026
16 September 2026
NCT07746960 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
ACG102 in Systemic Lupus Erythematosus: NCT07749430 Clinical Landscape Report 2026
16 September 2026
NCT07749430 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RO7845860 (F. Hoffmann-La Roche Ltd.) in Multiple sclerosis relapse: NCT07749157 Clinical Landscape Report 2026
16 September 2026
NCT07749157 clinical landscape for Multiple sclerosis relapse: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mepolizumab in Pulmonary Disease, Chronic Obstructive: NCT07749001 Clinical Landscape Report 2026
16 September 2026
NCT07749001 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…